News + Filings Holdings
|
NOTTINGHAM ADVISORS, INC.
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 11,979 | -200 | 303,188,000 | -89,098,000 | $25,309.96 |
| 03/31/2023 | Revance Therapeutics, Inc. | RVNC | 12,179 | -1,133 | 392,286,000 | 146,546,000 | $32,210.03 |
| 12/31/2022 | Revance Therapeutics, Inc. | RVNC | 13,312 | 0 | 245,740,000 | 245,556,000 | $18,460.04 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 13,312 | 0 | 184,000 | -76,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 13,312 | 0 | 260,000 | 43,000 | $19.53 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 13,312 | 0 | 217,000 | -178,000 | $16.30 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 13,312 | 0 | 395,000 | 23,000 | $29.67 |
| 03/31/2021 | Revance Therapeutics, Inc. | RVNC | 13,312 | 0 | 372,000 | -5,000 | $27.94 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 13,312 | 0 | 377,000 | 42,000 | $28.32 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 13,312 | 0 | 335,000 | -14,000 | $25.17 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 13,312 | 2,000 | 349,000 | 182,000 | $26.22 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 11,312 | 1,308 | 167,000 | 5,000 | $14.76 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 10,004 | -2,000 | 162,000 | 6,000 | $16.19 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 12,004 | 2,000 | 156,000 | 26,000 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 10,004 | 0 | 130,000 | -28,000 | $12.99 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 10,004 | -1,308 | 158,000 | -123,000 | $15.79 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 11,312 | 0 | 281,000 | 0 | $24.84 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 11,312 | -2,000 | 281,000 | -84,000 | $24.84 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 11,312 | 0 | 348,000 | 0 | $30.76 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 11,312 | 0 | 348,000 | -56,000 | $30.76 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 11,312 | 0 | 404,000 | 92,000 | $35.71 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 11,312 | -2,000 | 312,000 | -39,000 | $27.58 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 13,312 | 0 | 351,000 | 74,000 | $26.37 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 13,312 | 0 | 277,000 | 1,000 | $20.81 |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 13,312 | 0 | 276,000 | 60,000 | $20.73 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 13,312 | -3,000 | 216,000 | -6,000 | $16.23 |
| 06/30/2016 | Revance Therapeutics, Inc. | RVNC | 16,312 | -2,016 | 222,000 | -404,000 | $13.61 |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 18,328 | 18,328 | 626,000 | 626,000 | $34.16 |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 18,328 | 18,328 | 626,000 | 626,000 | $34.16 |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 18,328 | 18,328 | 545,000 | 545,000 | $29.74 |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 18,328 | 18,328 | 586,000 | 586,000 | $31.97 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 18,764 | 18,764 | 389,000 | 389,000 | $20.73 |
| 12/31/2014 | Revance Therapeutics, Inc. | RVNC | 23,018 | 23,018 | 390,000 | 390,000 | $16.94 |
| << Prev Next >> |
|